Addendum to the note for guidance on antiarrhythmics on atrial fibrillation and atrial flutter - Scientific guideline

This document is an addendum to the note for guidance on antiarrhythmics. It provides guidance for the evaluation of new medicinal products or drugs used in the antiarrhythmic treatment of atrial fibrillation.

Keywords: Atrial fibrillation, rhythm control, rate control, cardioversion

Current effective version

Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter

Adopted Reference Number: EMA/CHMP/EWP/213056/2010 Legal effective date: 01/02/2011

Document history

Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter

Adopted Reference Number: EMA/CHMP/EWP/213056/2010 Legal effective date: 01/02/2011

Draft note for guidance on antiarrhytmics addendum on atrial fibrillation

Draft: consultation closed Reference Number: EMEA/CHMP/EWP/352438/2008

Concept paper on the need for revision of the note for guidance on antiarrhythmics (CPMP/EWP/237/95)

Reference Number: EMEA/CHMP/EWP/358487/2006